NHS Supply Chain Air Purification — Innova NanoJet Accepted with NanoJet® Technology & AirSancta® CDa Series

FOR IMMEDIATE RELEASE:

London, UK – 10 November 2025 - NHS Supply Chain Air Purification

Innova NanoJet Technologies Ltd. Announces NHS Supply Chain Acceptance of NanoJet® Technology and AirSancta® CDa Series—Poised to Strengthen UK Defence Against Influenza and Avian Flu Outbreaks

London, UK – 11 November 2025  – Innova NanoJet Technologies Ltd. (“Innova NanoJet”) is proud to announce that it has been accepted into the NHS Supply Chain framework for NHS Supply Chain air purification, marking a significant milestone in our mission to deliver advanced air-protection solutions across the UK healthcare sector. This inclusion affirms our cutting-edge NanoJet® technology and AirSancta® CDa product line as trusted assets for infection-control, indoor-air purification and environmental decontamination.

Why this matters now

Health-authorities are warning that the UK is facing a potentially severe influenza season, with experts cautioning it could be the worst in a decade.

Simultaneously, signs show that avian influenza (“bird-flu”) is spreading among poultry and wild bird populations in the UK, with some virology experts warning it could be the most infectious yet.

In this context, NHS hospitals, clinics and other care facilities are facing heightened pressure to enhance infection-control, air-hygiene and aerosol-management capabilities.

How NanoJet® Technology & AirSancta® CDa Products Help

NanoJet® employs a filter-less, water-based ultra-fine droplet aerosol technology that generates trillions of ~100 nm particles to capture and neutralise airborne pathogens, including influenza viruses and potentially aerosolised avian-flu virus particles.

When integrated into AirSancta® CDa air-purification and misting systems, this technology offers rapid air-turnover, surface-deposition of neutralising aerosol and far-reaching room coverage—complementing existing ventilation, filtration and surface-cleaning protocols.

With NHS Supply Chain access, UK healthcare facilities can now procure AirSancta® CDa systems at scale, enabling deployment in critical zones such as waiting rooms, inpatient wards, ICU/HDUs, staff break-rooms and communal areas—strengthening protection for patients (especially the immunocompromised and elderly), front-line staff and visitors alike.

By addressing both airborne and surface-borne pathways in enclosed indoor environments, this technology adds a layer of defence against rapid-spreading influenza strains and outbreaks of avian-origin flu that may cross into human-settings.